Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2023-05-24 14:44 Tx date 2023-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$163,613
+15,234 vol $10.74 each |
186,193 | |
Filed 2023-05-24 14:43 Tx date 2023-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+9,310 vol |
9,310 | |
Filed 2023-05-24 14:41 Tx date 2023-05-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-98,333.58
-8,733 vol $11.26 each |
40,000 | |
Filed 2023-05-24 14:40 Tx date 2023-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,733 vol |
48,733 | |
Filed 2023-05-24 14:37 Tx date 2023-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-8,733 vol |
0 | |
Filed 2022-07-11 13:17 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$36,200
+10,000 vol $3.62 each |
40,000 | |
Filed 2022-07-11 13:12 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-47,300
-10,000 vol $4.73 each |
170,959 | |
Filed 2022-05-23 11:20 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$167,307
+14,612 vol $11.45 each |
180,959 | |
Filed 2022-05-23 11:18 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+8,733 vol |
8,733 | |
Filed 2022-05-23 11:17 Tx date 2015-05-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-17 17:06 Tx date 2021-06-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$403,122
+31,347 vol $12.86 each |
166,347 | |
Filed 2020-12-31 10:32 Tx date 2020-12-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$39,600
+10,000 vol $3.96 each |
30,000 | |
Filed 2020-12-31 10:32 Tx date 2020-12-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-39,600
-10,000 vol $3.96 each |
135,000 | |
Filed 2020-06-16 11:57 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$472,500
+30,000 vol $15.75 each |
145,000 | |
Filed 2020-06-03 14:27 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
||
Filed 2020-06-03 14:27 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
145,000 | |
Filed 2020-05-25 16:02 Tx date 2020-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$69,822
+16,200 vol $4.31 each |
20,000 | |
Filed 2020-05-25 15:59 Tx date 2020-05-19 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-69,822
-16,200 vol $4.31 each |
115,000 | |
Filed 2019-07-09 18:43 Tx date 2019-07-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$16,377
+3,800 vol $4.31 each |
3,800 | |
Filed 2019-07-09 18:42 Tx date 2015-05-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-07-09 18:41 Tx date 2019-07-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-3,800 vol |
131,200 | |
Filed 2019-07-05 12:37 Tx date 2019-07-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$125,850
+15,000 vol $8.39 each |
135,000 | |
Filed 2019-02-01 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$241,199
+30,000 vol $8.04 each |
120,000 | |
Filed 2018-02-09 Tx date 2018-02-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$192,600
+30,000 vol $6.42 each |
90,000 | |
Filed 2017-04-28 Tx date 2017-04-26 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$189,000
+20,000 vol $9.45 each |
60,000 | |
Filed 2017-03-02 Tx date 2017-02-16 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$47,300
+10,000 vol $4.73 each |
40,000 | |
Filed 2016-03-28 Tx date 2016-03-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$39,600
+10,000 vol $3.96 each |
30,000 | |
Filed 2015-06-03 Tx date 2015-06-02 |
$AUP
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$86,199
+20,000 vol $4.31 each |
20,000 | |
Filed 2015-06-03 Tx date 2015-05-26 |
$AUP
Aurinia Pharmaceuticals Inc. |
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|